|
Diagnosis
and Evaluation |
|
Home > Database
> Diagnosis
and Evaluation
|
|
|
Contents
|
|
|
| |
|
|
|
Astrocytic
Tumors
|
 
|
|
|
|
Jun Chen, Shu-Lan Huang, Tao Li and
Xi-Lan Chen
In vivo research in astrocytoma cell proliferation with 1H-magnetic
resonance spectroscopy: correlation with histopathology and immunohistochemistry
Neuroradiology. 2006 May;48(5):312-8. Epub
2006 Mar 22.
.JPG)
Abstract
|
|
|
Miyamoto
J, Tatsuzawa K, Owada K, Kawabe T, Sasajima H, Mineura K
Usefulness and limitations of fluorine-18-fluorodeoxyglucose positron
emission tomography for the detection of malignancy of orbital tumors
Neurol Med Chir (Tokyo). 2008;48(11):495-9. Release Date: November 25, 2008
Abstract | .png)
Reprint
|
|
|
Majós
C, Bruna J, Juliŕ-Sapé M, Cos M, Camins A, Gil M, Acebes JJ, Aguilera C,
Arús C.
Proton
MR spectroscopy provides relevant prognostic information in high-grade
astrocytomas.
AJNR
Am J Neuroradiol. 2011
Jan;32(1):74-80. Epub 2010 Oct 28.
Abstract |
Reprint |
.gif) Related articles
|
| |
Toshinari
Misaki, Takaaki Beppu, Takashi Inoue, Kuniaki Ogasawara, Akira Ogawa,
Hiroyuki Kabasawa
Use
of fractional anisotropy value by diffusion tensor MRI for preoperative
diagnosis of astrocytic tumors: case report
Journal
of Neuro-Oncology, 70(3):
343-348, December 2004. (Abstract+)
|
|
|
Zhang
K, Li C, Liu Y, Li L, Ma X, Meng X, Feng D
Evaluation of invasiveness of astrocytoma using 1H-magnetic resonance
spectroscopy: correlation with expression of matrix metalloproteinase-2
Neuroradiology. 2007
Nov;49(11):913-9.
Epub 2007 Sep 1
Abstract
|
|
|
Atyp.
Teratoid/Rhabdoid T.
|
|
|
|
|
Warmuth-Metz M, Bison B, Dannemann-Stern E, Kortmann R, Rutkowski S, Pietsch
T
CT
and MR imaging in atypical teratoid/rhabdoid tumors of the central nervous
system
Neuroradiology. 2008
May;50(5):447-52. Epub 2008 Mar 15
Abstract
|
|
|
Choroid
Plexus Papilloma
|
|
|
|
D'Ambrosio
AL, O'Toole JE, Connolly ES Jr, Feldstein NA
Villous
hypertrophy versus choroid plexus papilloma: a case report demonstrating a
diagnostic role for the proliferation index
Pediatr Neurosurg. 2003 Jul;39(2):91-6
|
|
|
CNS
Lymphoma
|
|
|
| |
Neuwelt EA, Guastadisegni PE, Varallyay
P, Doolittle ND
Imaging changes and cognitive
outcome in primary CNS lymphoma after enhanced chemotherapy delivery
AJNR Am J
Neuroradiol. 2005 Feb;26(2):258-65
|
|
Soussain
C, Muldoon LL, Varallyay C, Jahnke K, Depaula L, Neuwelt EA.
Characterization and magnetic resonance imaging of a rat model of human
B-cell central nervous system lymphoma.
Clin
Cancer Res. 2007 Apr 15;13(8):2504-11.
PMID: 17438111 [PubMed - in process]
|
|
|
Taillibert S, Guillevin R, Menuel C, Sanson M,
Hoang-Xuan K, Chiras J, Duffau H
Brain lymphoma: usefulness of the magnetic resonance spectroscopy
J Neurooncol.
2008 Jan;86(2):225-9.
Epub 2007 Sep 4
Abstract
|
|
|
Brain
Tumors
|
|
|
|
Auer
T, Schwarcz A, Janszky J, Horvath Z, Kosztolanyi P, Doczi T.
Application of functional MR-images acquired at low field in planning of
neurosurgical operation close to an eloquent brain area
Ideggyogy Sz. 2007 Jan
20;60(1-2):35-40. Hungarian.
PMID: 17432092 [PubMed - in process]
|
| |
A Bizzi, U.
Danesi, B. Pollo, L. Bissola, P. Ferroli, C. Solero, A. Boiardi, G. Broggi
H-MR
Spectroscopic Imaging-guided Surgery of Brain Tumors and correlation with
Neuropathology
Proc. Int. Symp.
“New Treatments for Brain Tumors: Gene Therapy and Neural Stem Cells”,
Parma, Italy, October 17-20, 2001, Abstract
No. O-1
|
|
|
Boss
A, Bisdas S, Kolb A, Hofmann M, Ernemann U, Claussen CD, Pfannenberg C,
Pichler BJ, Reimold M, Stegger L
Hybrid
PET/MRI of intracranial masses: initial experiences and comparison to PET/CT
J
Nucl Med. 2010 Aug;51(8):1198-205. Epub 2010 Jul 21
Abstract |
Related articles
|
|
William G. Bradley, MD, PhD
Achieving Gross Total Resection of
Brain Tumors: Intraoperative MR Imaging Can Make a Big Difference
American Journal of Neuroradiology 23:348-349, March 2002. (PDF Full text)
|
|
Broholm H,
Rubin I, Kruse A, Braendstrup O, Schmidt K, Skriver EB, Lauritzen M
Nitric
oxide synthase expression and enzymatic activity in human brain tumors
Clin Neuropathol. 2003 Nov-Dec;22(6):273-81
|
|
Brown
GG, Clark C, Liu TT.
Measurement of cerebral perfusion with arterial spin labeling: Part 2.
Applications.
J
Int Neuropsychol Soc. 2007 May;13(3):526-38.
PMID: 17445302 [PubMed - in process]
|
|
|
Clarke
JL, Chang S
Pseudoprogression and pseudoresponse: challenges in brain tumor imaging
Curr Neurol Neurosci Rep. 2009 May;9(3):241-6
Abstract
|
|
|
Dacic S.
An
update in molecular diagnostics of solid tumors.
Arch
Pathol Lab Med. 2011 May;135(5):535-6.
Abstract |
Reprint |
Related articles
|
|
|
D'Souza MM, Sharma R,
Tripathi M, Panwar P, Jaimini A, Mondal A.
Novel positron
emission tomography radiotracers in brain tumor imaging.
Indian J Radiol Imaging.
2011 Jul-Sep;21(3):202-8.
Online since 24 September 2011
Abstract | .png)
Full
text |
Related articles
|
|
|
Feldman SC, Chu D, Schulder M, Barry M, Cho ES, Liu WC
The
blood oxygen level-dependent functional MR imaging signal can be used to
identify brain tumors and distinguish them from normal tissue.
AJNR
Am J Neuroradiol. 2009 Feb;30(2):389-95
Abstract
|
|
|
Galldiks N, Kracht LW, Berthold F, Miletic H,
Klein JC, Herholz K, Jacobs AH, Heiss WD
[(11)C]-L:
-Methionine positron emission tomography in the management of children and
young adults with brain tumors
J Neurooncol.
2009 Jul 4. [Epub ahead of print]
Abstract |
Full text |
Reprint
|
|
|
Gaviani P, Silvani A,
Lamperti E, Botturi A, Simonetti G, Ferrari D, Salmaggi A.
Neuro-oncological
diagnosis in patients without histological confirmation.
Neurol Sci. 2011
Oct 13. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Geerts
J, Martens M, Vandevenne JE, Gelin G, Grieten M, Weyns F, Stinissen P,
Palmers Y, Wuyts J.
Functional magnetic resonance imaging for preoperative
localisation of eloquent brain areas relative to brain tumours: clinical
implementation in a regional hospital.
JBR-BTR.
2007 Jul-Aug;90(4):258-63.
Abstract
|
|
|
Gonzalez-Segura A, Morales JM, Gonzalez-Darder JM, Cardona-Marsal R,
Lopez-Gines C, Cerda-Nicolas M, Monleon D.
Magnetic resonance microscopy at 14 tesla and correlative histopathology
of human brain tumor tissue.
PLoS One. 2011;6(11):e27442.
Abstract |
Reprint |
Related articles
|
| |
Grosu AL,
Lachner R, Wiedenmann N, Stark S, Thamm R, Kneschaurek P, Schwaiger M, Molls M,
Weber WA
Validation
of a method for automatic image fusion (BrainLAB System) of CT data and
11C-methionine-PET data for stereotactic radiotherapy using a LINAC: first
clinical experience
Int J Radiat Oncol Biol Phys. 2003 Aug 1;56(5):1450-63
|
|
|
Hall WA, Kim P, Truwit CL.
Functional magnetic resonance imaging-guided brain tumor resection
Top Magn Reson Imaging. 2009 Jan;19(4):205-12
Abstract
|
|
|
Hourani
R, Brant LJ, Rizk T, Weingart JD, Barker PB, Horská A.
Can proton MR spectroscopic and perfusion imaging differentiate between
neoplastic and nonneoplastic brain lesions in adults?
AJNR
Am J Neuroradiol. 2008 Feb;29(2):366-72.
Epub 2007 Nov 30
Abstract |
Full text |
Reprint
|
| |
Kajimoto
K, Oku N, Kimura Y, Kato H, Tanaka MR, Kanai Y, Kitagawa K, Maruno M,
Yoshimine T, Hori M, Hatazawa J.
Crossed cerebellar diaschisis: a positron emission
tomography study with L-[methyl-11C]methionine and
2-deoxy-2-[18F]fluoro-D-glucose.
Ann Nucl Med.
2007 Feb;21(2):109-13.
PMID: 17424977 [PubMed - in process]
|
|
Kuhn
MJ, Picozzi P, Maldjian JA, Schmalfuss IM, Maravilla KR, Bowen BC, Wippold FJ
2nd, Runge VM, Knopp MV, Wolansky LJ, Gustafsson L, Essig M, Anzalone N.
Evaluation of intraaxial enhancing brain tumors on magnetic resonance
imaging: intraindividual crossover comparison of gadobenate dimeglumine and
gadopentetate dimeglumine for visualization and assessment, and implications
for surgical intervention.
J Neurosurg. 2007
Apr;106(4):557-66.
PMID: 17432704 [PubMed - in process]
|
| |
S. M. Kurian, E. B. Crowell
Concordance of FDG-PET scan and MRI- spectroscopy in
primary and metastatic intracranial tumors
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1551
|
|
|
Li YD, Geng DY, Zhang QB, Jiang SH
Discrepancy between the dynamic computed tomography and t2* magnetic
resonance perfusion imaging in brain tumors: a report of 2 cases
J Comput Assist Tomogr. 2007 Nov-Dec;31(6):896-900
Abstract
|
|
|
Lucignani
G.
Hints on new applications of emission tomography and magnetic resonance in
neuro-oncology.
Eur
J Nucl Med Mol Imaging. 2007 Jun 29; [Epub ahead of print] No
abstract available.
PMID: 17604987 [PubMed - as supplied by publisher]
|
|
Madhusoodanan
S, Danan D, Moise D.
Psychiatric manifestations of brain tumors: diagnostic
implications.
Expert
Rev Neurother. 2007 Apr;7(4):343-9.
PMID: 17425489 [PubMed - in process]
|
| |
Mardor Y,
Pfeffer R, Spiegelmann R, Roth Y, Maier SE, Nissim O, Berger R, Glicksman A,
Baram J, Orenstein A, Cohen JS, Tichler T
Early
Detection of Response to Radiation Therapy in Patients With Brain Malignancies
Using Conventional and High b-Value Diffusion-Weighted Magnetic Resonance
Imaging
J Clin Oncol 2003 Mar 15;21(6):1094-100
|
| |
Meyer
PT, Schreckenberger M, Spetzger U, Meyer GF, Sabri O, Setani KS, Zeggel T,
Buell U
Comparison of visual and ROI-based
brain tumour grading using 18F-FDG PET: ROC analyses
Eur J Nucl Med. 2001 Feb;28(2):165-74
|
|
|
Nabavi A, Goebel S, Doerner L, Warneke N, Ulmer
S, Mehdorn M.
Awake craniotomy and intraoperative magnetic resonance imaging: patient
selection, preparation, and technique
Top Magn Reson Imaging. 2009 Jan;19(4):191-6
Abstract
|
| |
E.
A. Neuwelt, L. Konyves-Kolonics, M. Haluska
Ferumoxtran-10
enhanced MR in variety of intracranial tumors and other lesions
39th ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No.
488
|
| |
Jeffrey R. Petrella, MD, Lubdha M. Shah,
MD, Katy M. Harris, BS, Allen H. Friedman, MD, Timothy M. George, MD, John H.
Sampson, MD, PhD, Joseph S. Pekala, MD and James T. Voyvodic, PhD
Preoperative Functional MR Imaging Localization of
Language and Motor Areas: Effect on Therapeutic Decision Making in Patients with
Potentially Resectable Brain Tumors
Radiology 2006 (September) 240: 793-802. Published online before print July 20
2006, 10.1148/radiol.2403051153
|
|
|
Pollo
B.
Neuropathological
diagnosis of brain tumours.
Neurol Sci. 2011 Oct 19;.
[Epub ahead of print]
Abstract |
Related articles
|
|
|
Okamoto
S, Shiga T, Hattori N, Kubo N, Takei T, Katoh N, Sawamura Y, Nishijima K,
Kuge Y, Tamaki N.
Semiquantitative analysis of C-11 methionine PET may distinguish brain tumor
recurrence from radiation necrosis even in small lesions.
Ann Nucl Med. 2010 Dec 28;. [Epub ahead of print]
Abstract |
Related articles
|
| |
Pirotte B,
Goldman S, Salzberg S, Wikler D, David P, Vandesteene A, Van Bogaert P, Salmon
I, Brotchi J, Levivier M
Combined
positron emission tomography and magnetic resonance imaging for the planning of
stereotactic brain biopsies in children: experience in 9 cases
Pediatr Neurosurg 2003 Mar;38(3):146-55
|
|
|
Plesec TP, Prayson RA.
Frozen section discrepancy in the evaluation of central nervous system
tumors.
Arch Pathol
Lab Med. 2007 Oct;131(10):1532-40.
Full text
|
Reprint
|
|
|
Prabhakar
R, Haresh KP, Ganesh T, Joshi RC, Julka PK, Rath GK.
Comparison of computed tomography and magnetic
resonance based target volume in brain tumors.
J
Cancer Res Ther. 2007 Apr-Jun;3(2):121-3.
Full text
|
Reprint
|
|
|
Prins, Robert M. Ph.D.; Bruhn, Kevin W. Ph.D.;
Craft, Noah M.D., Ph.D.; Lin, Jia Wei M.D.; Kim, Choong-Hyun M.D., Ph.D.;
Odesa, Sylvia K. B.S.; Miller, Jeff F. Ph.D.; Liau, Linda M. M.D., Ph.D.
Central Nervous System Tumor Immunity Generated by a Recombinant
Listeria monocytogenes Vaccine Targeting Tyrosinase Related Protein-2 and
Real-Time Imaging of Intracranial Tumor Burden
Neurosurgery. 58(1):169-178, January 2006
Abstract
|
|
|
James M. Provenzale, MD, Srinivasan Mukundan,
PhD, MD and Daniel P. Barboriak, MD
Diffusion-weighted and Perfusion MR Imaging for Brain Tumor
Characterization and Assessment of Treatment Response
Radiology. 2006 Jun;239(3):632-49; DOI:
10.1148/radiol.2393042031
Abstract
|
|
Rueger
MA, Kracht LW, Hilker R, Thiel A, Sobesky J, Winkeler A, Thomas AV,
Heneka MT, Graf R, Herholz K, Heiss WD, Jacobs AH.
Role of in vivo imaging of the central nervous system
for developing novel drugs.
Q
J Nucl Med Mol Imaging. 2007 Jun;51(2):164-81.
PMID: 17420717 [PubMed - in process]
|
|
|
Saraswathy
A, Jayasree RS, Baiju KV, Gupta AK, Pillai VP
Optimum Wavelength for the Differentiation of Brain Tumor Tissue Using
Autofluorescence Spectroscopy
Photomed Laser Surg. 2008 Nov 23;. [Epub ahead of print]
Abstract
|
| |
Schwindack
C, Siminotto
E, Meyer
M, McNamara
A, Marshall
I, Wardlaw
JM, Whittle
IR
Real-time functional magnetic resonance imaging (rt-fMRI)
in patients with brain tumours: preliminary findings using motor and
language paradigms
Br J
Neurosurg. 2005 Feb;19(1):25-32
|
|
|
Seidl
Z, Vymazal J, Mechl M, Goyal M, Herman M, Colosimo C, Pasowicz M, Yeung R,
Paraniak-Gieszczyk B, Yemen B, Anzalone N, Citterio A, Schneider G,
Bastianello S, Ruscalleda J.
Does
Higher Gadolinium Concentration Play a Role in the Morphologic Assessment of
Brain Tumors? Results of a Multicenter Intraindividual Crossover Comparison
of Gadobutrol versus Gadobenate Dimeglumine (the MERIT Study).
AJNR Am J Neuroradiol. 2012 Mar 1. [Epub
ahead of print]
Abstract |
Related articles
|
|
Talbot
JN, Kerrou K, Montravers F, Nataf V, Chevalme Y.
FDOPA PET has clinical utility in brain tumour imaging: a proposal for a
revision of the recent EANM guidelines.
Eur
J Nucl Med Mol Imaging. 2007 Apr 17; [Epub ahead of print] No
abstract available.
PMID: 17437107 [PubMed - as supplied by publisher]
|
|
|
Terakawa
Y, Tsuyuguchi N, Iwai Y, Yamanaka K, Higashiyama S, Takami T, Ohata K
Diagnostic Accuracy of 11C-Methionine PET for Differentiation of Recurrent
Brain Tumors from Radiation Necrosis After Radiotherapy
J
Nucl Med. 2008 Apr 15; [Epub ahead of print]
Abstract
|
| |
Katherine E. Warren
NMR Spectroscopy and Pediatric Brain Tumors
The Oncologist, Vol. 9, No. 3, 312–318, June 2004. (PDF Full text)
|
|
|
Young
GS.
Advanced MRI of adult brain tumors.
Neurol Clin.
2007 Nov;25(4):947-73.
Abstract
|
|
Zamboni
SL, Loenneker T, Boltshauser E, Martin E, Il'yasov KA.
Contribution of Diffusion Tensor MR Imaging in
Detecting Cerebral Microstructural Changes in Adults with
Neurofibromatosis Type 1.
AJNR
Am J Neuroradiol. 2007 Apr;28(4):773-6.
PMID: 17416837 [PubMed - in process]
|
|
|
Diagnostic
Markers
|
|
|
|
|
Baraniskin A, Kuhnhenn J, Schlegel U, Maghnouj A, Zöllner H, Schmiegel
W, Hahn S, Schroers R.
Identification of microRNAs in the cerebrospinal fluid as biomarker for
the diagnosis of glioma.
Neuro Oncol. 2011 Sep 21;. [Epub ahead of print]
Abstract |
Reprint |
Related articles
|
|
|
Hottinger AF, Iwamoto FM,
Karimi S, Riedel E, Dantis J, Park J, Panageas KS, Lassman AB, Abrey LE,
Fleisher M, Holland EC, DeAngelis LM, Hormigo A.
YKL-40 and MMP-9 as serum markers for patients
with primary central nervous system lymphoma.
Ann Neurol. 2011
Jul;70(1):163-9. doi: 10.1002/ana.22360. Epub 2011 Mar 9.
Abstract |
Related articles
|
|
|
Iwamoto
FM, Hottinger AF, Karimi S, Riedel E, Dantis J, Jahdi M, Panageas KS,
Lassman AB, Abrey LE, Fleisher M, Deangelis LM, Holland EC, Hormigo A.
Serum YKL-40 is a marker of
prognosis and disease status in high-grade gliomas.
Neuro Oncol. 2011 Aug 10;. [Epub
ahead of print]
Abstract
|
Related
articles
|
|
|
Jung
CS, Unterberg AW, Hartmann C.
Diagnostic markers for
glioblastoma.
Histol Histopathol. 2011 Oct;26(10):1327-41.
Abstract |
Reprint |
Related articles
|
|
|
Nilsson RJ, Balaj L, Hulleman E, van Rijn S, Pegtel DM, Walraven M, Widmark A,
Gerritsen WR, Verheul HM, Vandertop WP, Noske DP, Skog J, Würdinger
T.
Blood platelets contain
tumor-derived RNA biomarkers.
Blood. 2011 Aug 10;. [Epub
ahead of print]
Abstract
|
Related
articles
|
|
|
Shi W, Lv C, Qi J, Zhao W, Wu X, Jing R, Wu X, Ju
S, Chen J.
Prognostic Value of Free DNA Quantification in
Serum and Cerebrospinal Fluid in Glioma Patients.
J Mol Neurosci. 2011 Sep 1;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Smith
ER, Zurakowski D, Saad A, Scott RM, Moses MA.
Urinary Biomarkers Predict Brain Tumor Presence and
Response to Therapy
American Association of Neurological Surgeons 76th Annual Meeting: Abstract
629. Presented April 28, 2008
Abstract |
.gif) News
|
|
|
Wakabayashi
T, Natsume A, Hatano H, Fujii M, Shimato S, Ito M, Ohno M, Ito S, Ogura M,
Yoshida J
p16
promoter methylation in the serum as a basis for the molecular diagnosis of
gliomas
Neurosurgery. 2009
Mar;64(3):455-61
Abstract
|
|
|
Diffuse
Astrocytoma
|
|
|
|
Bela Bodey, Vivian Bodey, Stuart E. Siegel,
Hans E. Kaiser
Mage-1, a cancer-testis antigen, and p53 expression in
childhood astrocytomas as an indicator of tumor progression
Proceedings
of the AACR, Volume 44, 2nd ed., July 2003, Abstract No. 158
|
|
|
Ehrenfeld CE, Maschke M, Dörfler A, Reinhardt
V, Koeppen S
Is stereotactic biopsy a reliable method to differentiate tumor from
radiation necrosis?
Clin Neuropathol 2002 Jan-Feb;21(1):9-12
Abstract
|
|
Schlemmer
HP, Bachert P, Henze M, Buslei R, Herfarth KK, Debus J, van KG
Differentiation
of radiation necrosis from tumor progression using proton magnetic resonance
spectroscopy
Neuroradiology 2002 Mar;44(3):216-22
|
|
|
DIPG
|
|
|
|
|
Steffen-Smith EA, Venzon DJ, Bent RS, Hipp SJ, Warren KE.
Single-
and Multivoxel Proton Spectroscopy in Pediatric Patients With Diffuse
Intrinsic Pontine Glioma.
Int
J Radiat Oncol Biol Phys. 2012 Mar 23. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Disappearing
Lesions
|
|
|
|
|
Sutherland CS, Kelly JJ, Morrish W, Sutherland GR.
Identification
of disappearing brain lesions with intraoperative magnetic resonance imaging
prevents surgery.
Neurosurgery.
2010 Oct;67(4):1061-5; discussion 1065.
Abstract |
Related articles
|
|
|
Edema
|
|
|
|
Kimura
T, Ohkubo M, Igarashi H, Kwee IL, Nakada T.
Increase in glutamate as a sensitive indicator of extracellular matrix
integrity in peritumoral edema: a 3.0-tesla proton magnetic resonance
spectroscopy study.
J Neurosurg. 2007
Apr;106(4):609-13.
PMID: 17432711 [PubMed - in process]
|
|
|
Zinn
PO, Majadan B, Sathyan P, Singh SK, Majumder S, Jolesz FA, Colen RR.
Radiogenomic Mapping of
Edema/Cellular Invasion MRI-Phenotypes in Glioblastoma Multiforme.
PLoS One. 2011;6(10):e25451.
Epub 2011 Oct 5.
Abstract |
Reprint |
Related articles
|
|
|
Enhancement
|
|
|
|
|
Kamel
MH, Kelleher M, O'riordan C, Keohane C, O'sullivan M.
CT and MRI 'ring sign' may be due to demyelination: diagnostic pitfall.
Br J Neurosurg.
2007 Jun;21(3):309-11.
PMID: 17612927 [PubMed - in process]
|
|
|
Kleijn A, Chen JW, Buhrman JS, Wojtkiewicz GR, Iwamoto Y, Lamfers ML,
Stemmer-Rachamimov AO, Rabkin SD, Weissleder R, Martuza RL, Fulci G.
Distinguishing
inflammation from tumor and peritumoral edema by myeloperoxidase magnetic
resonance imaging.
Clin
Cancer Res. 2011 Jul 1;17(13):4484-93. Epub 2011 May 10.
Abstract |
Related articles
|
|
|
Ependymoma
|
|
|
|
|
U-King-Im JM, Taylor MD, Raybaud C.
Posterior
fossa ependymomas: new radiological classification with surgical correlation.
Childs
Nerv Syst. 2010 Dec;26(12):1765-72. Epub 2010 Aug 3.
Abstract |
Related articles
|
|
|
Glioblastoma
|
|
|
|
|
Alexiou GA, Tsiouris S, Kyritsis AP, Fotakopoulos G, Goussia
A, Voulgaris S, Fotopoulos AD.
The
Value of 99mTc-Tetrofosmin Brain SPECT in Predicting Survival in Patients
with Glioblastoma Multiforme.
J
Nucl Med. 2010 Dec;51(12):1923-6. Epub 2010 Nov 15.
Abstract |
Reprint |
Related articles
|
|
|
Ahluwalia
MS, Wen PY.
Antiangiogenic therapy for
patients with glioblastoma: current challenges in imaging and future
directions.
Expert Rev Anticancer Ther.
2011 May;11(5):653-6.
Abstract |
Reprint |
Related articles
|
|
|
Bohman
LE, Swanson KR, Moore JL, Rockne R, Mandigo C, Hankinson T, Assanah M,
Canoll P, Bruce JN.
Magnetic
Resonance Imaging Characteristics of Glioblastoma Multiforme: Implications
for Understanding Glioma Ontogeny.
Neurosurgery.
2010 Sep 23. [Epub ahead of print]
Abstract |
Related articles
|
|
Burger PC, Dubois PJ, Schold SC Jr, Smith KR Jr, Odom GL, Crafts
DC, Giangaspero F
Computerized
tomographic and pathologic studies of the untreated, quiescent, and
recurrent glioblastoma multiforme
J Neurosurg. 1983 Feb;
58(2): 159-69
|
|
|
Colavolpe C, Guedj E, Metellus P, Barrie M,
Figarella-Branger D, Mundler O, Chinot O
FDG-PET to predict different patterns of progression in multicentric
glioblastoma: a case report
J Neurooncol. 2008 Jun 21; [Epub ahead of print]
Abstract
|
|
|
Crawford FW, Khayal IS, McGue C, Saraswathy S,
Pirzkall A, Cha S, Lamborn KR, Chang SM, Berger MS, Nelson SJ.
Relationship of pre-surgery metabolic and physiological MR imaging
parameters to survival for patients with untreated GBM
J Neurooncol. 2008 Nov 15; [Epub ahead of print]
Abstract
|
|
|
Elstner
A, Stockhammer F, Nguyen-Dobinsky TN, Nguyen QL, Pilgermann I, Gill A, Guhr
A, Zhang T, von Eckardstein K, Picht T, Veelken J, Martuza RL, von Deimling
A, Kurtz A.
Identification of diagnostic serum protein profiles of glioblastoma patients
J Neurooncol. 2010 Jul 9;. [Epub ahead of print]
Abstract
|
|
|
Farace P, Amelio D, Ricciardi GK, Beltramello A.
Baseline Preadjuvant Magnetic Resonance Imaging for Response Assessment
and for Planning Radiotherapy in Glioblastoma.
J Clin Oncol. 2010 Dec 28;. [Epub ahead of print]
Abstract |
Reprint |
Related articles
|
|
Hochberg FH,
Pruitt A
Assumptions
in the radiotherapy of glioblastoma
Neurology. 1980 Sep; 30(9): 907-11
|
|
|
Huang
BC, Geng DY, Zee CS, Ji YM, Cheng HX, Dai YM
A unique magnetic resonance imaging feature of glioblastoma multiforme:
the 'pseudopalisade' sign
J Int Med Res. 2010 Mar-Apr;38(2):686-93
Abstract |
Reprint
|
|
|
Jung
CS, Foerch C, Schänzer A, Heck A, Plate KH, Seifert V, Steinmetz H, Raabe
A, Sitzer M
Serum GFAP is a diagnostic marker for glioblastoma multiforme
Brain. 2007
Dec;130(Pt 12):3336-41. Epub 2007 Nov 12
Abstract |
Full text |
Reprint
|
| |
Samira Guccione,
Yishan Yang, Ron Homer, Steven Chang, Griff Harsh, Scott Atlas, Mark Bednarski
The use of MRI in patients with glioblastoma
multiforme to identify regions of vascular permeability for genomic analysis
Proceedings
of the AACR, Volume 44, 2nd ed., July 2003, Abstract No. 2958
|
|
|
Kazim
SF, Bhatti AU.
Glioblastoma multiforme masquerading as intracerebral haemorrhage: a
diagnostic dilemma.
J Pak Med Assoc. 2011 Feb;61(2):196-7.
Abstract |
Reprint |
Related articles
|
|
|
Kleinberg
L, Yoon G, Weingart JD, Parisi M, Olivi A, Detorie NA, Chan TA
Imaging After GliaSite Brachytherapy: Prognostic MRI Indicators of Disease
Control and Recurrence
Int J Radiat Oncol Biol Phys. 2009 Apr 23;. [Epub ahead of print]
Abstract
|
|
|
Laprie A, Catalaa I, Cassol E, McKnight TR,
Berchery D, Marre D, Bachaud JM, Berry I, Moyal EC
Proton magnetic resonance spectroscopic imaging in newly diagnosed
glioblastoma: predictive value for the site of postradiotherapy relapse in a
prospective longitudinal study
Int J Radiat Oncol Biol Phys. 2008 Mar 1; 70(3):773-81; Epub 2008 Feb 6
Abstract
|
|
|
Li
WB, Tang K, Zhang W, Yan W, You G, Li SW, Zhang L, Huang YJ, Jiang T.
Relationship between magnetic resonance imaging and molecular pathology in
patients with glioblastoma multiforme.
Chin Med J (Engl). 2011 Sep;124(17):2589-92.
Abstract |
Reprint |
Related articles
|
|
|
Mukundan S, Holder C, Olson JJ.
Neuroradiological assessment of newly diagnosed glioblastoma
J Neurooncol.
2008 Sep;89(3):259-69.
Epub 2008 Aug 20
Abstract
|
|
|
Piroth
MD, Pinkawa M, Holy R, Klotz J, Nussen S, Stoffels G, Coenen HH, Kaiser HJ,
Langen KJ, Eble MJ
Prognostic
Value of Early [(18)F]Fluoroethyltyrosine Positron Emission Tomography After
Radiochemotherapy in Glioblastoma Multiforme
Int
J Radiat Oncol Biol Phys. 2010 Jun 18. [Epub ahead of print]
Abstract
|
| |
Principi M, Italiani M, Guiducci A, Aprile I, Muti M,
Giulianelli G, Ottaviano P
Perfusion
MRI in the evaluation of the relationship between tumour growth, necrosis and
angiogenesis in glioblastomas and grade 1 meningiomas
Neuroradiology 2003 Apr;45(4):205-11
|
|
|
Sanal
HT, Bulakbasi N, Kocaoglu M, Onguru O, Chen L.
Giant Infantile Gliosarcoma: Magnetic Resonance Imaging Findings
J Child Neurol. 2008 Apr 10; [Epub ahead of print]
Abstract |
Reprint
|
|
|
Saraswathy S, Crawford FW, Lamborn KR, Pirzkall
A, Chang S, Cha S, Nelson SJ.
Evaluation of MR markers that predict survival in patients with newly
diagnosed GBM prior to adjuvant therapy
J Neurooncol. 2008 Sep 23; [Epub ahead of print]
Abstract
|
|
|
Seidel C, Dorner N, Osswald M, Wick A, Platten M, Bendszus M, Wick W.
Does
age matter? - A MRI study on peritumoral edema in newly diagnosed primary
glioblastoma.
BMC Cancer. 2011 Apr 12;11(1):127. [Epub ahead of print]
Abstract |
Reprint |
Related articles
|
|
|
Shaan M. Raza, B.S.; Frederick F. Lang, M.D.; Bharat B.
Aggarwal, Ph.D.; Gregory N. Fuller, Ph.D., M.D.; David M. Wildrick, Ph.D.; Raymond
Sawaya,M.D.
Necrosis and Glioblastoma: A Friend or a Foe?
A Review and a Hypothesis
Neurosurgery. 51(1):2-13, July 2002
Abstract
|
|
|
Spence
AM, Muzi M, Swanson KR, O'Sullivan F, Rockhill JK, Rajendran JG, Adamsen TC,
Link JM, Swanson PE, Yagle KJ, Rostomily RC, Silbergeld DL, Krohn KA
Regional Hypoxia in Glioblastoma Multiforme Quantified with
[18F]Fluoromisonidazole Positron Emission Tomography before Radiotherapy:
Correlation with Time to Progression and Survival
Clin Cancer Res. 2008 May 1;14(9):2623-30
Abstract
|
| |
Kevin
S. Tralins, MD, James G. Douglas, MD, MS, Keith J. Stelzer, MD, PhD, David
A. Mankoff, MD, Daniel L. Silbergeld, MD, Robert Rostomilly, MD, Sharon Hummel,
MS, Jeff Scharnhorst, BS, Kenneth A. Krohn, PhD and Alexander M. Spence, MD
Volumetric Analysis of 18F-FDG PET
in Glioblastoma Multiforme: Prognostic Information and Possible Role in
Definition of Target Volumes in Radiation Dose Escalation
Journal of Nuclear Medicine Vol. 43 No. 12 1667-1673
|
|
|
Saxena
V, Gonzalez-Gomez I, Laug WE.
A Non-invasive, In Vivo Technique for Monitoring
Vascular Status of Glioblastoma During Angiogenesis.
Technol
Cancer Res Treat. 2007 Dec;6(6):641-50.
Abstract
|
|
|
Swanson
KR, Chakraborty G, Wang CH, Rockne R, Harpold HL, Muzi M, Adamsen TC, Krohn
KA, Spence AM
Complementary but Distinct Roles for MRI and 18F-Fluoromisonidazole PET in
the Assessment of Human Glioblastomas
J Nucl Med. 2008 Dec 17; [Epub ahead of print]
Abstract
|
|
Wallner
KE, Galicich JH, Krol G, Arbit E, Malkin MG
Patterns
of failure following treatment for glioblastoma multiforme and anaplastic
astrocytoma
Int J Radiat Oncol Biol Phys. 1989 Jun; 16(6): 1405-9
|
|
|
Young GS, Macklin EA, Setayesh K, Lawson JD, Wen PY, Norden AD, Drappatz J,
Kesari S.
Longitudinal
MRI evidence for decreased survival among periventricular glioblastoma.
J
Neurooncol. 2010 Dec 5. [Epub ahead of print]
Abstract |
Reprint |
Related articles
|
|
Zhang R,
Tremblay TL, McDermid A, Thibault P, Stanimirovic D
Identification
of differentially expressed proteins in human glioblastoma cell lines and tumors
Glia 2003 Apr 15;42(2):194-208
|
|
Pseudoprogression
|
|
|
|
Young RJ, Gupta A, Shah AD, Graber JJ, Zhang Z, Shi W, Holodny AI, Omuro AM.
Potential
utility of conventional MRI signs in diagnosing pseudoprogression in
glioblastoma.
Neurology. 2011 May
31;76(22):1918-24.
Abstract
|
Related
articles
|
|
Recurrent
Tumors
|
|
|
|
Chamberlain
MC.
Radiographic patterns of relapse in glioblastoma.
J
Neurooncol. 2010 Jun 10. [Epub ahead of print]
Abstract |
Reprint |
Related articles
|
|
|
Vrabec M, Van Cauter S, Himmelreich U, Van
Gool SW, Sunaert S, De Vleeschouwer S, Suput D, Demaerel P.
MR perfusion and diffusion imaging in the follow-up of recurrent
glioblastoma treated with dendritic cell immunotherapy: a pilot study.
Neuroradiology. 2010 Nov 25;. [Epub ahead of print]
Abstract |
Reprint |
Related articles
|
|
|
Gliomas
|
|
|
|
|
Atkinson M, Juhasz C, Shah J, Guo X, Kupsky W,
Fuerst D, Johnson R, Watson C
Paradoxical imaging findings in cerebral gliomas
J Neurol Sci. 2008 Feb 5; [Epub ahead of print]
Abstract
|
|
|
Awasthi
R, Rathore RK, Soni P, Sahoo P, Awasthi A, Husain N, Behari S, Singh RK,
Pandey CM, Gupta RK.
Discriminant
analysis to classify glioma grading using dynamic contrast-enhanced MRI and
immunohistochemical markers.
Neuroradiology.
2011 May 4. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Bobek-Billewicz
B, Stasik-Pres G, Majchrzak H, Zarudzki L
Differentiation between brain tumor recurrence and radiation injury using
perfusion, diffusion-weighted imaging and MR spectroscopy
Folia Neuropathol. 2010;48(2):81-92. Online publish date: 2010-07-01
Abstract |
Full text |
Reprint
|
|
|
Brekke
C, Williams SC, Price J, Thorsen F, Modo M.
Cellular multiparametric MRI of neural stem cell therapy in a rat glioma
model.
Neuroimage. 2007 Jun 14; [Epub
ahead of print]
PMID: 17613248 [PubMed - as supplied by publisher]
|
| |
Cao Y, Tsien CI, Nagesh V, Junck L, Ten Haken
R, Ross BD, Chenevert TL, Lawrence TS
Clinical investigation survival
prediction in high-grade gliomas by MRI perfusion before and during early stage
of RT
Int
J Radiat Oncol Biol Phys. 2005 Nov 17; [Epub ahead of
print]
|
|
|
de Witt MC, de Bruin HG, Ejkenboom W, Sillevis
Smitt PAE and van den Bent
Immediate post-radiotherapy changes in malignant glioma can mimic tumor
progression
Neurology 63:535-537, 2004 Aug 10
Abstract |
Full text |
Reprint
|
| |
De
Witte O, Goldberg I, Wikler D, Rorive S, Damhaut P, Monclus M, Salmon I,
Brotchi J, Goldman S
Positron emission tomography with
injection of methionine as a prognostic factor in glioma
J
Neurosurg. 2001 Nov;95(5):746-50
|
| |
E.
Galanis, M. J. Maurer, K. V. Ballman, J. O'Fallon, R. Sykora, R. Castillo,
J. C. Buckner, B. J. Erickson
Validation of neuroradiologic response assessment in
gliomas: RECIST (1D) vs 2D measurements vs computer-assisted tumor area vs
volume
39th ASCO Annual Meeting.
Chicago, IL. May 31-June 3, 2003. Abstract No.
423
|
|
Hakyemez B, Erdogan C, Ercan I, Ergin N, Uysal S, Atahan
S
High-grade and low-grade gliomas: differentiation by
using perfusion MR imaging
Clin
Radiol. 2005 Apr;60(4):493-502
|
|
|
Kato
T, Shinoda J, Nakayama N, Miwa K, Okumura A, Yano H, Yoshimura S, Maruyama
T, Muragaki Y, Iwama T.
Metabolic Assessment of Gliomas Using 11C-Methionine, [18F]
Fluorodeoxyglucose, and 11C-Choline Positron-Emission Tomography
AJNR
Am J Neuroradiol. 2008 Apr 3; [Epub ahead of print]
Abstract
|
|
|
Keller DM
Intraoperative MRI Facilitates Complete
Glioma Resection.
Report on the intervention of Christian Senft, MD at the
American Association of Neurological Surgeons
(AANS) 79th Annual Meeting: Plenary Session I. Presented April 11, 2011, and
of a comment of Mitchel Berger, MD on Dr.
Senft's study.
Abstract
|
News
|
|
Kelly PJ,
Daumas-Duport C, Scheithauer BW, Kall BA, Kispert DB
Stereotactic
histologic correlations of computed tomography- and magnetic resonance
imaging-defined abnormalities in patients with glial neoplasms
Mayo Clin Proc. 1987 Jun; 62(6): 450-9
|
|
|
Kuhnt D, Ganslandt O, Schlaffer SM, Buchfelder M, Nimsky C.
Quantification
of glioma removal by intraoperative high-field magnetic resonance imaging -
an update.
Neurosurgery. 2011 May 26. [Epub
ahead of print]
Abstract |
Related articles
|
|
Kircher
MF, Mahmood U, King RS, Weissleder R, Josephson L
A
multimodal nanoparticle for preoperative magnetic resonance imaging and
intraoperative optical brain tumor delineation
Cancer Res. 2003 Dec 1;63(23):8122-5
|
|
|
Konukoglu
E, Clatz O, Bondiau PY, Delingette H, Ayache N.
Extrapolating glioma invasion margin in brain magnetic resonance images:
Suggesting new irradiation margins
Med Image Anal. 2009 Dec 3;. [Epub ahead of print]
Abstract
|
| |
Kumar
AJ, Leeds NE, Fuller GN, Van Tassel P, Maor MH, Sawaya RE, Levin VA
Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced
necrosis of the brain after treatment
Radiology. 2000 Nov;217(2):377-84
Abstract |
Full text |
Reprint
|
| |
Kuznetsov YE, Caramanos Z, Antel SB, Preul MC, Leblanc R,
Villemure JG, Pokrupa R, Olivier A, Sadikot A, Arnold DL
Proton magnetic resonance spectroscopic imaging can
predict length of survival in patients with supratentorial gliomas
Neurosurgery. 2003 Sep;53(3):565-76
|
|
|
la Fougčre C, Suchorska B, Bartenstein P, Kreth FW, Tonn JC.
Molecular
imaging of gliomas with PET: Opportunities and limitations.
Neuro Oncol. 2011 Jul 13. [Epub
ahead of print]
Abstract |
Related articles
|
|
|
Law
M, Young RJ, Babb JS, Peccerelli N, Chheang S, Gruber ML, Miller DC,
Golfinos JG, Zagzag D, Johnson G.
Gliomas: predicting time to progression or survival with cerebral blood
volume measurements at dynamic susceptibility-weighted contrast-enhanced
perfusion MR imaging
Radiology. 2008 May;247(2):490-8.
Epub 2008 Mar 18
Abstract |
News
|
|
|
Leach PA, Estlin EJ, Coope DJ, Thorne JA, Kamaly-Asl ID
Diffuse
brainstem gliomas in children: should we or shouldn't we biopsy?
Br J
Neurosurg. 2008 Oct;22(5):619-24
Abstract
|
|
|
Li DL, Xu YK, Wang QS, Wu HB, Li HS.
11C-methionine
and 18F-fluorodeoxyglucose positron emission tomography/CT in the evaluation
of patients with suspected primary and residual/recurrent gliomas.
Chin Med J (Engl).
2012 Jan;125(1):91-6.
Abstract |
Full text
|
Related articles
|
| |
Lichy MP,
Bachert P, Henze M, Lichy CM, Debus J, Schlemmer HP
Monitoring
individual response to brain-tumour chemotherapy: proton MR spectroscopy in a
patient with recurrent glioma after stereotactic radiotherapy
Neuroradiology. 2003 Dec 18 [Epub ahead of print].
|
|
|
Liu
ZL, Zhou Q, Zeng QS, C-F L, Zhang K.
Noninvasive Evaluation of
Cerebral Glioma Grade by Using Diffusion-weighted Imaging-guided
Single-voxel Proton Magnetic Resonance Spectroscopy.
J Int Med Res. 2012
Jan;40(1):76-84.
Abstract |
Reprint |
Related articles
|
|
|
Lu
H, Pollack E, Young R, Babb JS, Johnson G, Zagzag D, Carson R, Jensen JH,
Helpern JA, Law M.
Predicting Grade of Cerebral Glioma Using
Vascular-Space Occupancy MR Imaging.
AJNR
Am J Neuroradiol. 2007 Nov 1; [Epub ahead of print]
Abstract
|
|
|
Lupo
JM, Chuang CF, Chang SM, Barani IJ, Jimenez B, Hess CP, Nelson SJ.
7-Tesla
Susceptibility-Weighted Imaging to Assess the Effects of Radiotherapy on
Normal-Appearing Brain in Patients with Glioma.
Int J Radiat Oncol Biol
Phys. 2011 Oct 12;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Majós C, Aguilera C, Alonso J, Juliŕ-Sapé M,
Castańer S, Sánchez JJ, Samitier A, León A, Rovira A, Arús C
Proton MR Spectroscopy Improves Discrimination between Tumor and
Pseudotumoral Lesion in Solid Brain Masses
AJNR Am J Neuroradiol. 2008 Dec 18; [Epub ahead of print]
Abstract |
Reprint
|
| |
Yael
Mardor, Roberto Spiegelmann, Yiftach Roth, Arie Orenstein, Stephan E. Maier,
Ouzi Nissim, Zvi Ram, Jacob Baram, Thomas Tichler, Raphael Pfeffer
Pre-treatment prediction of brain tumor response to
radiation therapy using high diffusion-weighted MRI
Proceedings of the AACR, Volume 44, 2nd ed., July 2003, Abstract No. 2547
|
|
Murphy PS, Viviers L, Abson C, Rowland IJ, Brada M, Leach
MO, Dzik-Jurasz AS
Monitoring temozolomide treatment of low-grade glioma
with proton magnetic resonance spectroscopy
Br J Cancer. 2004 Feb 23;90(4):781-6
|
|
|
Nelson
SJ.
Assessment of therapeutic
response and treatment planning for brain tumors using metabolic and
physiological MRI.
NMR Biomed. 2011 Apr 27;. [Epub
ahead of print]
Abstract |
Related articles
|
|
|
Nikiforova
MN, Hamilton RL.
Molecular diagnostics of gliomas.
Arch Pathol Lab Med. 2011 May;135(5):558-68.
Abstract |
Reprint |
Related articles
|
|
M.V.
Padma, S. Said,
M. Jacobs, D.R. Hwang, K. Dunigan, M. Satter, B. Christian, J. Ruppert, T.
Bernstein, G. Kraus, J.C. Mantil
Prediction of Pathology and Survival by FDG PET in Gliomas
Journal of Neuro-Oncology, 64 (3): 227-237, September 2003
|
| |
Susan
Pannullo, D. C
Shungu, R. L DeLaPaz, M. Odaimi, J. Serventi, L. Heller, C. M Balmaceda
Use
of magnetic resonance spectroscopy (MRS) in malignant gliomas treated with
temozolomide (TMZ)
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.
2101
|
| |
Michail Plotkin, Julia Eisenacher,
Harald
Bruhn, Reinhard Wurm, Roger Michel, Florian Stockhammer, Annelie
Feußner,
Oliver Dudeck, Peter Wust, Roland Felix, Holger Amthauer
123I-IMT
SPECT and 1HMR-Spectroscopy at 3.0T in the Differential
Diagnosis of Recurrent or Residual Gliomas: A Comparative Study
J Neurooncol, 70
(1):49-58, Oct. 2004.
(Abstract+)
|
|
|
Santra
A, Kumar R, Sharma P, Bal C, Kumar A, Julka PK, Malhotra A.
F-18 FDG PET-CT in patients with recurrent glioma: Comparison with contrast
enhanced MRI.
Eur J Radiol. 2011 Feb 23;. [Epub ahead of print]
Abstract |
Related articles
|
|
Scott
JN, Brasher PM, Sevick RJ, Rewcastle NB, Forsyth PA
How
often are nonenhancing supratentorial gliomas malignant? A population
study
Neurology. 2002 Sep
24;59(6):947-9
|
|
|
Schaller BJ, Cornelius JF, Sandu N, Buchfelder M.
Molecular imaging of brain tumors personal experience and review of the
literature
Curr Mol Med. 2008 Dec;8(8):711-26
Abstract
|
|
Takahashi Y,
Imahori Y, Mineura K
Prognostic
and therapeutic indicator of fluoroboronophenylalanine positron emission
tomography in patients with gliomas
Clin Cancer Res. 2003 Dec 1;9(16):5888-95
|
|
|
Tanwar MK, Gilbert MR, Holland EC.
Gene expression microarray analysis
reveals YKL-40 to be a potential serum marker for malignant character in human
glioma
Cancer Res 2002 Aug 1;62(15):4364-8
Abstract |
Full text |
Reprint
|
|
Vos
MJ, Uitdehaag BM, Barkhof F, Heimans JJ, Baayen HC, Boogerd W, Castelijns
JA, Elkhuizen PH, Postma TJ
Interobserver
variability in the radiological assessment of response to chemotherapy in glioma
Neurology 2003 Mar 11;60(5):826-30
|
|
|
Winterstein
M, Münter MW, Burkholder I, Essig M, Kauczor HU, Weber MA
Partially
Resected Gliomas: Diagnostic Performance of Fluid-attenuated Inversion
Recovery MR Imaging for Detection of Progression
Radiology.
2010 Feb 1. [Epub ahead of print]
Abstract
|
|
Recurrent
Tumors
|
|
|
|
Fueger BJ, Czernin J, Cloughesy T, Silverman DH, Geist CL, Walter MA,
Schiepers C, Nghiemphu P, Lai A, Phelps ME, Chen W
Correlation
of 6-18F-fluoro-L-Dopa PET Uptake with Proliferation and Tumor Grade in
Newly Diagnosed and Recurrent Gliomas
J
Nucl Med. 2010 Sep 16. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Gliomas
(High-Grade)
|
|
|
|
|
Brat DJ, Prayson RA, Ryken TC, Olson JJ.
Diagnosis of malignant glioma: role of neuropathology
J Neurooncol.
2008 Sep;89(3):287-311.
Epub 2008 Aug 20
Abstract
|
|
|
Burnet NG, Lynch AG, Jefferies SJ, Price SJ,
Jones PH, Antoun NM, Xuereb JH, Pohl U.
High grade glioma: Imaging combined with pathological grade defines
management and predicts prognosis
Radiother
Oncol. 2007 Nov 26; [Epub ahead of print]
Abstract
|
|
|
Fink
JR, Carr RB, Matsusue E, Iyer RG, Rockhill JK, Haynor DR, Maravilla KR.
Comparison of 3 Tesla
proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing
glioma recurrence from posttreatment effects.
J Magn Reson Imaging.
2011 Oct 14;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Gonzalez-Bonet LG.
Stereotactic biopsy versus spectroscopy in cases of gliomas with a high
degree of malignancy. A review of the literature
Rev Neurol.
2008 Sep 16-30;47(6):310-4.
Spanish
Abstract |
Reprint
|
|
|
Grabner
G, Nöbauer I, Elandt K, Kronnerwetter C, Woehrer A, Marosi C, Prayer D,
Trattnig S, Preusser M.
Longitudinal brain
imaging of five malignant glioma patients treated with bevacizumab using
susceptibility-weighted magnetic resonance imaging at 7 T.
Magn Reson Imaging. 2011
Oct 6;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Hygino
da Cruz LC Jr, Rodriguez I, Domingues RC, Gasparetto EL, Sorensen AG.
Pseudoprogression and Pseudoresponse: Imaging Challenges in the Assessment
of Posttreatment Glioma.
AJNR Am J Neuroradiol. 2011 Mar 10;. [Epub ahead of print]
Abstract |
Reprint |
Related articles
|
|
|
Adília Hormigo, Bin Gu,
Sasan Karimi, Elyn Riedel, Katherine S.
Panageas, Mark A. Edgar, Meena K. Tanwar, Jasti
S. Rao, Martin Fleisher, Lisa M. DeAngelis
and Eric C. Holland
YKL-40 and Matrix Metalloproteinase-9 as Potential Serum Biomarkers for
Patients with High-Grade Gliomas
Clin
Cancer Res. 2006 Oct 1;12(19):5698-704.
|
|
|
Hutterer M, Nowosielski M, Putzer D, Waitz D, Tinkhauser G, Kostron H, Muigg
A, Virgolini IJ, Staffen W, Trinka E, Gotwald T, Jacobs AH, Stockhammer G.
O-(2-18F-Fluoroethyl)-L-Tyrosine
PET Predicts Failure of Antiangiogenic Treatment in Patients with Recurrent
High-Grade Glioma.
J
Nucl Med. 2011 Jun;52(6):856-64.
Abstract |
Related articles
|
|
|
Kim
YH, Oh SW, Lim YJ, Park CK, Lee SH, Kang KW, Jung HW, Chang KH.
Differentiating radiation necrosis from tumor recurrence in high-grade
gliomas: Assessing the efficacy of (18)F-FDG PET, (11)C-methionine PET and
perfusion MRI
Clin Neurol Neurosurg. 2010 Jul 7;. [Epub ahead of print]
Abstract
|
|
|
Pirotte BJ, Levivier M, Goldman S, Massager N,
Wikler D, Dewitte O, Bruneau M, Rorive S, David P, Brotchi J
Positron emission tomography-guided volumetric resection of
supratentorial high-grade gliomas: a survival analysis in 66 consecutive
patients
Neurosurgery. 2009 Mar;64(3):471-81
Abstract
|
|
|
Prat
R, Galeano I, Lucas A, Martínez JC, Martín M, Amador R, Reynés G.
Relative value of magnetic resonance spectroscopy, magnetic resonance
perfusion, and 2-((18)F) fluoro-2-deoxy-D-glucose positron emission
tomography for detection of recurrence or grade increase in gliomas
J Clin Neurosci. 2009 Dec 1. [Epub ahead of print]
Abstract
|
|
|
Sankar T, Caramanos Z, Assina R, Villemure JG,
Leblanc R, Langleben A, Arnold DL, Preul MC
Prospective serial proton MR spectroscopic assessment of response to
tamoxifen for recurrent malignant glioma
J Neurooncol.
2008 Jul 4. [Epub ahead of print]
Abstract
|
|
|
Shirahata M, Iwao-Koizumi K, Saito S, Ueno N,
Oda M, Hashimoto N, Takahashi JA, Kato K
Gene expression-based molecular diagnostic system for malignant gliomas is
superior to histological diagnosis
Clin
Cancer Res. 2007 Dec 15;13(24):7341-56
Abstract
|
|
|
V.
Vallejos, C.
BalańM. Fraile,
Y. Roussos, J. Capellades, P. Cuadras, R. Ballester, A. Ley, A. Arellano,
R. Rosell
Use of 201Tl SPECT Imaging to Assess the Response to Therapy in Patients with
High Grade Gliomas
Journal of Neuro-Oncology, 59 (1): 81-90, August 2002
Abstract |
Reprint
|
|
|
Gliomas
(Low-Grade)
|
|
|
|
|
Danchaivijitr
N, Waldman AD, Tozer DJ, Benton CE, Brasil Caseiras G, Tofts PS, Rees JH, Jäger
HR
Low-grade gliomas: do changes in rCBV measurements at longitudinal
perfusion-weighted MR imaging predict malignant transformation?
Radiology. 2008 Apr;247(1):170-8.
Abstract |
News
|
| |
De
Witte O, Oulad Ben Taib N, Branle F, Rorive S, Brotchi J, Goldman S
Contribution of PET to the
management of patients with low-grade glioma
Neurochirurgie.
2004 Sep;50(4):468-73
|
|
|
Einar Goebell, MD, Susanne Paustenbach, Ole Vaeterlein, MD, Xiao-Qi Ding,
PhD, MD, Oliver Heese, MD, Jens Fiehler, MD, Thomas Kucinski, MD,
Christian Hagel, MD, Manfred Westphal, MD and Hermann Zeumer, MD
Low-Grade and Anaplastic Gliomas: Differences in Architecture Evaluated
with Diffusion-Tensor MR Imaging
Radiology, 2006;239:217-222;
Published online before print February 16,
2006; DOI: 10.1148/radiol.2383050059
Abstract
|
|
|
Guillevin
R, Menuel C, Taillibert S, Capelle L, Costalat R, Abud L, Habas C, De Marco
G, Hoang-Xuan K, Chiras J, Vallée JN.
Predicting
the outcome of grade II glioma treated with temozolomide using proton
magnetic resonance spectroscopy.
Br
J Cancer. 2011 May 24. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Guillevin R, Menuel C, Duffau H, Kujas M,
Capelle L, Aubert A, Taillibert S, Idbaih A, Pallud J, Demarco G, Costalat
R, Hoang-Xuan K, Chiras J, Vallée JN
Proton magnetic resonance spectroscopy predicts proliferative activity in
diffuse low-grade gliomas
J Neurooncol.
2007 Dec 28; [Epub ahead of print]
Abstract
|
|
|
Gupta R, Mohindra S, Gupta K
Demyelination or low-grade glioma? A diagnostic dilemma
Surg Neurol.
2008 Feb 22; [Epub ahead of print]
Abstract
|
|
|
Hattingen E, Raab P, Franz K, Lanfermann H,
Setzer M, Gerlach R, Zanella FE, Pilatus U
Prognostic value of choline and creatine in WHO grade II gliomas
Neuroradiology. 2008
Jun 4. [Epub ahead of print]
Abstract |
Full text |
Reprint
|
| |
Marcus
Henze, MD, Ashour Mohammed, PhD, Heinz P. Schlemmer, MD, Klaus K.
Herfarth, MD, Simone Hoffner, MD, Sabine Haufe, MD, Walter Mier, PhD,
Michael Eisenhut, PhD, Jürgen Debus, MD, PhD and Uwe Haberkorn, MD
PET
and SPECT for Detection of Tumor Progression in Irradiated Low-Grade
Astrocytoma: A Receiver-Operating-Characteristic Analysis
Journal
of Nuclear Medicine, April 1 2004, Volume 45, CNO 4, Pages 579-586
|
| |
Herholz
K, Holzer T, Bauer B, Schroder R, Voges J, Ernestus RI, Mendoza G,
Weber-Luxenburger G, Lottgen J, Thiel A, Wienhard K, Heiss WD
11C-methionine
PET for differential diagnosis of low-grade gliomas
Neurology.
1998 May;50(5):1316-22
|
| |
Mandonnet
E, Delattre JY, Tanguy ML, Swanson KR, Carpentier AF, Duffau H, Cornu
P, Van Effenterre R, Alvord EC Jr, Capelle L
Continuous growth of mean
tumor diameter in a subset of grade II gliomas
Ann
Neurol. 2003 Apr;53(4):524-8
|
|
|
Law, Meng M.D.; Oh, Sarah M.D.; Johnson, Glyn
Ph.D.; Babb, James S. Ph.D.; Zagzag, David M.D., Ph.D.; Golfinos, John M.D.;
Kelly, Patrick J. M.D.
Perfusion Magnetic Resonance Imaging Predicts Patient Outcome as an
Adjunct to Histopathology: A Second Reference Standard in the Surgical and
Nonsurgical Treatment of Low-grade Gliomas
Neurosurgery. 58(6):1099-1107, June 2006
Abstract
|
Full text
|
Reprint
|
|
|
Lee EJ, Lee SK, Agid R, Bae JM, Keller A, Terbrugge K
Preoperative
grading of presumptive low-grade astrocytomas on MR imaging: diagnostic
value of minimum apparent diffusion coefficient
AJNR
Am J Neuroradiol. 2008 Nov;29(10):1872-7. Epub 2008 Aug 21
Abstract
|
| |
Novak L, Molnar P, Lengyel Z, Tron L
Does increased 18FDG uptake reflect malignant
transformation of a low-grade glioma? A diagnostic dilemma
Neurol
India. 2005 Mar;53(1):112-4. (PDF
Full text)
|
| |
Nuutinen
J, Sonninen P, Lehikoinen P, Sutinen E, Valavaara R, Eronen E,
Norrgard S, Kulmala J, Teras M, Minn H
Radiotherapy
treatment planning and long-term follow-up with [(11)C]methionine PET
in patients with low-grade astrocytoma
Int
J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):43-52
|
|
Pallud J, Mandonnet E, Duffau H, Kujas M, Guillevin
R, Galanaud D, Taillandier L, Capelle L.
Prognostic value of initial magnetic resonance imaging growth rates for World
Health Organization grade II gliomas.
Ann Neurol. 2006 Sep 18;60(3):380-383 [Epub ahead of print]
Abstract
|
| |
Pirzkall
A, Nelson SJ, McKnight TR, Takahashi MM, Li X, Graves EE, Verhey LJ,
Wara WW, Larson DA, Sneed PK
Metabolic
imaging of low-grade gliomas with three-dimensional magnetic resonance
spectroscopy
Int
J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1254-64
|
|
Ribom
D, Larsson A, Pietras K, Smits A
Growth
factor analysis of low-grade glioma CSF: PDGF and VEGF are not detectable
Neurol
Sci. 2003 Jun;24(2):70-3
|
|
Ribom
D, Westman-Brinkmalm A, Smits A, Davidsson P
Elevated levels of
alpha-2-Heremans-Schmid glycoprotein in CSF of patients with low-grade gliomas
Tumour
Biol. 2003 Mar-Apr;24(2):94-9
|
|
Ribom
D, Engler H, Blomquist E, Smits A
Potential
significance of (11)C-methionine PET as a marker for the radiosensitivity of
low-grade gliomas
Eur
J Nucl Med Mol Imaging. 2002 May;29(5):632-40. Epub 2002 Mar 5
|
|
Ribom
D, Eriksson A, Hartman M, Engler H, Nilsson A, Langstrom B, Bolander H,
Bergstrom M, Smits A
Positron
emission tomography (11)C-methionine and survival in patients with low-grade
gliomas
Cancer.
2001 Sep 15;92(6):1541-9
|
|
|
Seiz
M, Dimitrakopoulou-Strauss A, Schubert GA, Weinmann C, Strauss LG, Eisenhut
M, Tuettenberg J.
Differentiation between malignant transformation and tumour recurrence by
(68)Ga-bombesin and (18)F-FDG-PET, in patients with low grade gliomas
Hell J Nucl Med. 2008 Sep-Dec;11(3):149-52
Abstract
|
|
Walker C, du Plessis DG, Fildes D, Haylock B,
Husband D, Jenkinson MD, Joyce KA, Broome J, Kopitski K, Prosser J, Smith T,
Vinjamuri S, Warnke PC
Correlation of molecular genetics
with molecular and morphological imaging in gliomas with an oligodendroglial
component
Clin
Cancer Res. 2004 Nov 1;10(21):7182-91
|
|
|
Wyss
M, Hofer S, Bruehlmeier M, Hefti M, Uhlmann C, Bärtschi E, Buettner UW,
Roelcke U
Early
metabolic responses in temozolomide treated low-grade glioma patients
J Neurooncol.
2009 Apr 18. [Epub ahead of print]
Abstract
|
|
|
Gliomatosis
Cerebri
|
|
|
| |
Galanaud
D, Chinot O, Nicoli F, Confort-Gouny S, Le Fur Y, Barrie-Attarian M,
Ranjeva JP, Fuentes S, Viout P, Figarella-Branger D, Cozzone PJ
Use
of proton magnetic resonance spectroscopy of the brain to differentiate
gliomatosis cerebri from low-grade glioma
J Neurosurg 2003
Feb;98(2):269-76
|
|
|
Intracerebral Hematoma
|
|
|
| |
Minutoli F, Angileri FF, Cosentino S, Pecorella GR,
Cardali S, De Divitiis O, Germano A, Baldari S
99mTc-MIBI
SPECT in distinguishing neoplastic from nonneoplastic intracerebral hematoma
J Nucl Med. 2003 Oct;44(10):1566-73
|
|
|
Medulloepithelioma
|
|
|
|
Rajan Syal, Jaypal Reddy S, Raj Kumar, Isha Tyagi,
A.A. Wani Abrar, Narender Krishnani, Asht M. Mishra, Rakesh K. Gupta
Unusual Clinical and MRI Features of a Cerebellopontine
Angle Medulloepithelioma
Pediatr Neurosurg. 2006 Aug;42(5):299-303
Abstract
|
|
|
Medulloblastoma
|
|
|
|
|
Brasme
JF, Chalumeau M, Doz F, Lacour B, Valteau-Couanet D, Gaillard S, Delalande
O, Aghakhani N, Sainte-Rose C, Puget S, Grill J.
Interval between onset of
symptoms and diagnosis of medulloblastoma in children: distribution and
determinants in a population-based study.
Eur J Pediatr. 2011
May 3;. [Epub ahead of print]
Abstract |
Related articles
|
|
CM Coffin, JT Braun, MR Wick and LP Dehner
A clinicopathologic and immunohistochemical analysis
of 53 cases of medulloblastoma with emphasis on synaptophysin expression
Modern Pathology, 1990, Vol 3, CNO 2, 164-170 (Laboratory
Investigation,
Abstract)
|
|
|
Fruehwald-Pallamar
J, Puchner SB, Rossi A, Garre ML, Cama A, Koelblinger C, Osborn AG, Thurnher
MM.
Magnetic resonance imaging spectrum of medulloblastoma.
Neuroradiology. 2011 Jan 29;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Schwalbe
EC, Lindsey JC, Straughton D, Hogg TL, Cole M, Megahed H, Ryan SL, Lusher
ME, Taylor MD, Gilbertson RJ, Ellison DW, Bailey S, Clifford SC.
Rapid diagnosis of medulloblastoma molecular subgroups.
Clin Cancer Res. 2011 Feb 16;. [Epub ahead of print]
Abstract |
Related articles
|
|
Yuksel
M, Lutterbey G, Biersack HJ, Elke U, Hasan C, Gao Z, Bode U, Ezziddin S.
111In-pentetreotide scintigraphy in medulloblastoma: a comparison with
magnetic resonance imaging.
Acta Oncol.
2007;46(1):111-7.
PMID: 17438713 [PubMed - in process]
|
|
|
Meningioma
|
|
|
|
Ahmed
SN, Scozzafava J.
Images in clinical medicine. Meningioma.
N Engl J
Med. 2007 Apr 19;356(16):e14. No abstract available.
PMID: 17442901 [PubMed - indexed for MEDLINE]
|
|
|
Alexandru D, Glantz MJ, Kim L, Chamberlain MC, Bota DA.
Pulmonary
metastases in patients with recurrent, treatment-resistant meningioma:
Prognosis and identification by (111) indium-octreotide imaging.
Cancer. 2011 Mar 28. doi:
10.1002/cncr.26065. [Epub ahead of print]
Abstract |
Related articles
|
|
Henze M, Dimitrakopoulou-Strauss A, Milker-Zabel S, Schuhmacher J,
Strauss LG, Doll J, Macke HR, Eisenhut M, Debus J, Haberkorn U
Characterization of 68Ga-DOTA-D-Phe1-Tyr3-Octreotide
Kinetics in Patients with Meningiomas
J
Nucl Med. 2005 May;46(5):763-9.
|
|
|
Owen
CM, Schaller C, Binder DK.
The madness of Dionysus: a
neurosurgical perspective on Friedrich Nietzsche.
Neurosurgery. 2007
Sep;61(3):626-31;
discussion 631-2.
Full text
|
Reprint
|
|
Stenzel W, Rohn G, Miletic H, Radner H, Deckert M,
Ernestus RI.
Diagnostic impact of
ornithine decarboxylase in meningiomas
J Neurooncol. 2004 Jan;66(1-2):59-64.
|
|
|
Zhang
H, Rödiger LA, Shen T, Miao J, Oudkerk M
Perfusion MR imaging for differentiation of benign and malignant meningiomas
Neuroradiology. 2008
Apr 1; [Epub ahead of print]
Abstract |
Full text |
Reprint
|
|
|
Metastatic
Tumors
|
|
|
|
Dieta
Brandsma, Martin J.B. Taphoorn, Jaap C. Reijneveld, Thomas M. Nas, Emile
E. Voest, Klaas Nicolay, Erwin Blezer
MR Imaging of Mouse Leptomeningeal Metastases
Journal of Neuro-Oncology, 68 (2): 123-130, June 2004. (Abstract+)
|
|
|
Chamberlain
MC, Glantz M, Groves MD, Wilson WH
Diagnostic
tools for neoplastic meningitis: detecting disease, identifying patient risk,
and determining benefit of treatment
Semin Oncol.
2009 Aug;36(4 Suppl 2):S35-45
Abstract |
Full text |
Reprint
|
|
|
Dequesada IM, Quisling RG, Yachnis A, Friedman
WA
Can standard magnetic resonance imaging reliably distinguish recurrent
tumor from radiation necrosis after radiosurgery for brain metastases? A
radiographic-pathological study
Neurosurgery. 2008
Nov;63(5):898-903
Abstract
|
|
|
Kano
H, Kondziolka D, Lobato-Polo J, Zorro O, Flickinger JC, Lunsford LD
T1/T2 matching to differentiate tumor growth from radiation effects after
stereotactic radiosurgery
Neurosurgery. 2010 Mar;66(3):486-92.
Abstract
|
|
|
Kienast
Y, von Baumgarten L, Fuhrmann M, Klinkert WE, Goldbrunner R, Herms J,
Winkler F.
Real-time imaging reveals the single steps of brain metastasis formation
Nat Med. 2010 Jan;16(1):116-22
Abstract
|
|
Kimura T, Sako K, Tanaka K, Gotoh T, Yoshida H, Aburano T,
Tanaka T, Arai H, Nakada T
Evaluation of the response of
metastatic brain tumors to stereotactic radiosurgery by proton magnetic
resonance spectroscopy, 201TlCl single-photon emission computerized tomography,
and gadolinium-enhanced magnetic resonance imaging
J Neurosurg. 2004 May;100(5):835-41
|
|
|
Lee
HY, Lee KS, Kim BT, Cho YS, Lee EJ, Yi CA, Chung MJ, Kim TS, Kwon OJ, Kim H.
Diagnostic efficacy of PET/CT plus brain MR imaging for detection of
extrathoracic metastases in patients with lung adenocarcinoma
J Korean Med Sci. 2009 Dec;24(6):1132-8
Abstract |
Full text |
Reprint
|
|
|
Seute T, Leffers P, Ten Velde GP, Twijnstra A.
Detection of brain metastases from small cell lung cancer : consequences
of changing imaging techniques (CT versus MRI)
Cancer. 2008 Feb 29; [Epub
ahead of print]
Abstract
|
|
|
Patel TR, McHugh BJ, Bi WL,
Minja FJ, Knisely JP, Chiang VL.
A Comprehensive Review of MR Imaging Changes
Following Radiosurgery to 500 Brain Metastases.
AJNR
Am J Neuroradiol. 2011 Sep 15. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Methionine
PET
|
|
|
|
|
Kinoshita
M, Goto T, Arita H, Okita Y, Isohashi K, Kagawa N, Fujimoto Y, Kishima H,
Shimosegawa E, Saitoh Y, Hatazawa J, Hashimoto N, Yoshimine T.
Imaging (18)F-fluorodeoxy
glucose/(11)C-methionine uptake decoupling for identification of tumor cell
infiltration in peritumoral brain edema.
J Neurooncol. 2011 Aug 17;. [Epub
ahead of print]
Abstract |
Related articles
|
|
|
Neuroblastoma
|
|
|
|
Pearl GS,
Takei Y
Cerebellar
"neuroblastoma": nosology as it relates to medulloblastoma
Cancer.
1981 Feb 15;47(4):772-9
|
|
M
Lindskog, P Kogner, F Ponthan, P Schweinhardt, B Sandstedt, T Heiden, G
Helms and C Spenger
Noninvasive
estimation of tumour viability in a xenograft model of human neuroblastoma with
proton magnetic resonance spectroscopy (1H MRS)
British
Journal of Cancer, 88:
478 - 485,
10 Feb 2003
|
|
|
N
& Mixed N-Glial Tumors
|
|
|
|
|
Meyer
PT, Spetzger U, Mueller HD, Zeggel T, Sabri O, Schreckenberger M
High
F-18 FDG uptake in a low-grade supratentorial ganglioma: a positron emission
tomography case report
Clin Nucl Med. 2000 Sep;25(9):694-7
|
|
|
Non-CNS Neoplasms
|
|
|
|
|
Yaron Hassid, Edna Furman-Haran,
Raanan Margalit, Raya Eilam and Hadassa Degani
Noninvasive
Magnetic Resonance Imaging of Transport and Interstitial Fluid Pressure in
Ectopic Human Lung Tumors
Cancer Research, 66, 4159-4166, April 15, 2006
Abstract
|
News
|
|
Goodwin DA,
Meares CF, McCall MJ, McTigue M, Chaovapong W
Pre-targeted
immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens
J Nucl Med. 1988 Feb; 29(2): 226-34
|
|
Hormigo A, Liberato B, Lis E, DeAngelis LM
Nonconvulsive status epilepticus in patients with
cancer: imaging abnormalities
Arch Neurol. 2004 Mar;61(3):362-5. (Retrospective Study, Abstract)
|
|
|
Jun
Liu, Andrea L Levine, John S Mattoon, Mamoru Yamaguchi, Robert J Lee,
Xueliang Pan and Thomas J Rosol
Nanoparticles
as image enhancing agents for ultrasonography
Phys. Med. Biol.,
2006 May 7;51(9):2179-89; Epub 2006 Apr 10; doi:10.1088/0031-9155/51/9/004
Abstract
|
News
|
|
|
Oligodendroglioma
|
|
|
|
|
Agar NY, Golby AJ, Ligon KL, Norton I, Mohan V, Wiseman JM, Tannenbaum A,
Jolesz FA.
Development
of Stereotactic Mass Spectrometry for Brain Tumor Surgery.
Neurosurgery.
2010 Nov 25. [Epub ahead of print]
Abstract |
Related articles
|
|
F.
Giammarile, L.E. Cinotti, A. Jouvet, J.M. Ramackers, G. Saint Pierre, P.
Thiesse, E. Jouanneau, J. Guyotat, I. Pelissou-Guyotat, A. Setiey, J. Honnorat,
D. Le Bars, D. Frappaz
High and Low Grade Oligodendrogliomas
(ODG): Correlation of Amino-Acid and Glucose Uptakes Using PET and Histological
Classifications
Journal of Neuro-Oncology, 68 (3): 263-274, July 2004. (Abstract+)
|
|
|
Hunt JL
Molecular testing in solid tumors: an overview
Arch
Pathol Lab Med. 2008 Feb;132(2):164-7
Abstract |
Full text |
Reprint
|
|
Laigle-Donadey
F, Martin-Duverneuil N, Lejeune J, Criniere E, Capelle L, Duffau H, Cornu P,
Broet P, Kujas M, Mokhtari K, Carpentier A, Sanson M, Hoang-Xuan K, Thillet J,
Delattre JY
Correlations between
molecular profile and radiologic pattern in oligodendroglial tumors
Neurology.
2004 Dec 28;63(12):2360-2
|
|
|
Pediatric
Patients
|
|
|
|
Dorner
L, Fritsch MJ, Stark AM, Mehdorn HM.
Posterior fossa tumors in children: how long does it
take to establish the diagnosis?
Childs
Nerv Syst. 2007 Apr 12; [Epub ahead of print]
PMID: 17429658 [PubMed - as supplied by publisher]
|
|
|
Duffner
PK.
Diagnosis of brain tumors in children.
Expert Rev
Neurother. 2007 Jul;7(7):875-85.
PMID: 17610394 [PubMed - in process]
|
|
A
A. Tzika, Loukas G. Astrakas, David Zurakowski, Maria K. Zarifi, Tina P.
Young, Liliana Goumnerova, Douglas C. Anthony, Mark Kieran, Nancy J. Tarbell,
Peter M. Black
Predicting progression in children with pediatric brain
tumors using magnetic resonance neuroimaging
Proceedings of the AACR, Volume 44, 1st ed., March 2003, Abstract No. 3411
|
|
Laprie A, Pirzkall A, Haas-Kogan DA, Cha S, Banerjee A, Le TP, Lu Y,
Nelson S, McKnight TR
Longitudinal multivoxel MR spectroscopy study of
pediatric diffuse brainstem gliomas treated with radiotherapy
Int
J Radiat Oncol Biol Phys. 2005 May 1;62(1):20-31
|
|
|
Nath SK, Carmona R, Rose BS, Simpson DR, Russell M, Lawson JD, Mundt AJ,
Murphy KT.
Observed
magnetic resonance imaging changes in pediatric patients treated with
stereotactic radiosurgery for intracranial tumors.
Childs
Nerv Syst. 2011 Mar;27(3):399-406. Epub 2010 Oct 7.
Abstract |
Reprint |
Related articles
|
|
|
Panigrahy A, Nelson Jr MD, Finlay JL, Sposto R,
Krieger MD, Gilles FH, Blüml S.
Metabolism of diffuse intrinsic brainstem gliomas in children.
Neuro Oncol. 2007
Nov 14; [Epub ahead of print]
Abstract
|
|
|
Porto
L, Hattingen E, Pilatus U, Kieslich M, Yan B, Schwabe D, Zanella FE,
Lanfermann H.
Proton magnetic resonance
spectroscopy in childhood brainstem lesions.
Childs
Nerv Syst. 2007 Mar;23(3):305-14.
Epub 2006 Sep 16.
Full
text |
Reprint
|
|
Poussaint
TY, Phillips PC, Vajapeyam S, Fahey FH, Robertson RL, Osganian S,
Ramamurthy U, Mulkern RV, Treves ST, Boyett JM, Kun LE.
The neuroimaging center of the pediatric brain tumor
consortium-collaborative neuroimaging in pediatric brain tumor
research: a work in progress.
AJNR
Am J Neuroradiol. 2007 Apr;28(4):603-7.
PMID: 17416804 [PubMed - in process]
|
|
Samdani
A, Jallo GI.
Intraoperative MRI: Technology, Systems, and Application
to Pediatric Brain Tumors.
Surg
Technol Int. 2007;16:236-43.
PMID: 17429795 [PubMed - in process]
|
|
|
Samuel
AM.
PET/CT in pediatric oncology.
Indian J Cancer. 2010 Oct-Dec;47(4):360-70.
Abstract |
Full
text |
Related articles
|
|
|
Steffen-Smith
EA, Shih JH, Hipp SJ, Bent R, Warren KE.
Proton magnetic resonance
spectroscopy predicts survival in children with diffuse intrinsic pontine
glioma.
J Neurooncol. 2011 May 13;. [Epub
ahead of print]
Abstract |
Related articles
|
|
|
Zukotynski KA, Fahey FH, Kocak M, Alavi A, Wong TZ, Treves ST, Shulkin BL,
Haas-Kogan DA, Geyer JR, Vajapeyam S, Boyett JM, Kun LE, Poussaint TY.
Evaluation
of 18F-FDG PET and MRI Associations in Pediatric Diffuse Intrinsic Brain
Stem Glioma: A Report from the Pediatric Brain Tumor Consortium.
J
Nucl Med. 2011 Jan 13. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Pilomyxoid
Astrocytoma
|
|
|
|
|
Komotar RJ, Zacharia BE, Sughrue ME, Mocco J,
Carson BS, Tihan T, Otten ML, Burger PC, Garvin JH, Khandji AG, Anderson RC
Magnetic
resonance imaging characteristics of pilomyxoid astrocytoma
Neurol Res.
2008 Nov;30(9):945-51. Epub 2008 Jul 25
Abstract
|
|
|
Pleom.
Xanthoastrocytoma
|
|
|
|
|
Crespo-Rodriguez
AM, Smirniotopoulos JG, Rushing EJ.
MR and CT imaging of 24 pleomorphic xanthoastrocytomas (PXA) and a review of
the literature.
Neuroradiology. 2007
Apr;49(4):307-15. Epub 2007 Jan 5. Review.
PMID: 17205313 [PubMed - indexed for MEDLINE]
|
|
|
Proliferation
/Progression
|
|
|
|
Kremer
S, Pinel S, Vedrine PO, Bressenot A, Robert P, Bracard S, Plenat F.
Ferumoxtran-10 enhancement in orthotopic xenograft models of human brain
tumors: an indirect marker of tumor proliferation?
J Neurooncol.
2007 Apr 19; [Epub ahead of print]
PMID: 17443290 [PubMed - as supplied by publisher]
|
|
|
Mehta AI, Kanaly CW, Friedman AH, Bigner DD, Sampson JH.
Monitoring
radiographic brain tumor progression.
Toxins (Basel). 2011
Mar;3(3):191-200. Epub 2011 Mar 15.
Abstract |
Reprint |
Related articles
|
|
|
Radbruch A, Lutz K, Wiestler B, Bäumer P, Heiland S, Wick W, Bendszus M.
Relevance
of T2 signal changes in the assessment of progression of glioblastoma
according to the Response Assessment in Neurooncology criteria.
Neuro Oncol. 2011 Dec 6. [Epub
ahead of print]
Abstract |
Related articles
|
|
|
Recurrence
|
|
|
|
|
Alexiou GA, Fotopoulos AD, Papadopoulos A,
Kyritsis AP, Polyzoidis KS, Tsiouris S.
Evaluation
of brain tumor recurrence by (99m)Tc-tetrofosmin SPECT: a prospective pilot
study.
Ann
Nucl Med. 2007 Jul;21(5):293-8. Epub 2007 Jul 25.
Abstract |
Reprint |
Related articles
|
|
|
Heiss WD, Raab P,
Lanfermann H.
Multimodality
Assessment of Brain Tumors and Tumor Recurrence.
J
Nucl Med. 2011 Aug 12. [Epub ahead of print]
Abstract |
Reprint |
Related articles
|
|
|
Jain
R, Scarpace L, Ellika S, Schultz LR, Rock JP, Rosenblum ML, Patel SC, Lee TY,
Mikkelsen T.
First-pass perfusion computed tomography: initial experience in differentiating recurrent brain tumors
from radiation effects and radiation necrosis.
Neurosurgery.
2007 Oct;61(4):778-86;
discussion 786-7.
Abstract
|
|
|
Tan
H, Chen L, Guan Y, Lin X.
Comparison of MRI,
F-18 FDG, and 11C-Choline PET/CT for Their Potentials in Differentiating
Brain Tumor Recurrence From Brain Tumor Necrosis Following Radiotherapy.
Clin Nucl Med. 2011 Nov;36(11):978-81.
Abstract |
Related articles
|
|
|
Xiangsong
Z, Weian C.
Differentiation of recurrent astrocytoma from radiation necrosis: a pilot
study with 13N-NH3 PET.
J Neurooncol.
2007 May;82(3):305-11. Epub 2006 Nov 22.
PMID: 17120157 [PubMed - indexed for MEDLINE]
|
|
|
Rhabdomyosarcoma
|
|
|
|
|
Zhong J, Li ST, Yao XH, Jin B,
Wan L
An intrasellar rhabdomyosarcoma misdiagnosed as pituitary adenoma
Surg Neurol.
2007 Dec; 68 Suppl 2:S29-33
Abstract
|
|
|
Schwannoma
|
|
|
|
Colosimo C, Cerase A, Denaro L, Maira G, Greco R
Magnetic
resonance imaging of intramedullary spinal cord schwannomas. Report of two cases
and review of the literature
J Neurosurg. 2003 Jul;99(1 Suppl):114-7
|
|
|
Spinal Cord Tumors
|
|
|
|
|
Jo M. Wilmshurst, Sally F. Barrington, Dylan Pritchard, Tim Cox, Peter
Bullock, Michael Maisey, and Richard O. Robinson
Positron Emission Tomography in
Imaging Spinal Cord Tumors
Journal of Child Neurology, Jul 2000; vol. 15: pp. 465 - 472
Abstract |
Reprint
|
|
|
SPNET
|
|
|
|
VE
Gould, DS Jansson, WM Molenaar, LB Rorke, JQ Trojanowski, VM Lee, RJ Packer
and WW Franke
Primitive
neuroectodermal tumors of the central nervous system. Patterns of expression of
neuroendocrine markers, and all classes of intermediate filament proteins
Lab Invest. 1990 Apr;62(4):498-509
|
|
|
Stem
Cells
|
|
|
|
|
Tsurumi C, Esser N, Firat E, Gaedicke S, Follo M, Behe M, Elsässer-Beile U,
Grosu AL, Graeser R, Niedermann G.
Non-Invasive In Vivo Imaging of Tumor-Associated CD133/Prominin.
PLoS One. 2010 Dec 20;5(12):e15605.
Abstract |
Reprint
|
|
|
Therapy
Monitoring
|
|
|
|
|
Lindquist
D.
Science to Practice: Is there a role for MR imaging in monitoring gene
therapy response?
Radiology. 2007
Jun;243(3):611-2. No abstract available.
PMID: 17517921 [PubMed - indexed for MEDLINE]
|
|
|
Reif
R, Wang M, Joshi S, A'amar O, Bigio IJ.
Optical method for real-time monitoring of drug concentrations facilitates
the development of novel methods for drug delivery to brain tissue.
J Biomed Opt.
2007 May-Jun;12(3):034036.
PMID: 17614744 [PubMed - in process]
|
|
